GyneFix-Viz*: A Study of Serosal-Anchor (SA) Distance
Launched by WIEBE, ELLEN, M.D. · Nov 7, 2013
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. healthy women requesting intrauterine contraception
- • 2. willing to have a GyneFix IUD for pregnancy prevention
- • 3. able to return for a follow-up ultrasound
- • 4. able to read and understand consent form
- Exclusion Criteria:
- • 1. Any contraindications precluding insertion of an IUD (e.g., infection, cancer of the uterus, malformation etc.)
- • 2. Immediately after a pregnancy interruption \> 10 weeks gestation
About Wiebe, Ellen, M.D.
Dr. Ellen Wiebe, M.D., is a distinguished clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical practice and research, Dr. Wiebe specializes in innovative therapeutic approaches and is dedicated to conducting rigorous, ethically sound clinical trials. Her leadership in the field is characterized by a focus on patient safety, data integrity, and collaborative partnerships with healthcare professionals and research institutions. Through her efforts, she aims to contribute significantly to the development of new treatments and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Ellen R WIEBE, MD
Principal Investigator
University of BC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials